Unbiased AI-powered news
1 stories related to this topic, newest first.
medpagetoday.comObesity treatments have become the leading driver of pharmaceutical research and development gains, surpassing oncology. A Deloitte partner highlighted concentration risks for companies reliant on these drugs. Plus-size model Ashley Graham described the trend as disheartening for…